We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
-1.07%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$3.41B
AUM Growth
+$209M
Cap. Flow
+$293M
Cap. Flow %
8.59%
Top 10 Hldgs %
18.79%
Holding
129
New
4
Increased
103
Reduced
21
Closed
1

Sector Composition

Rank Sector Weight
1 Industrials 22.5%
2 Financials 14.47%
3 Technology 14.45%
4 Healthcare 11.13%
5 Consumer Discretionary 9.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDC icon
26
Belden
BDC
$3.97B
$39.7M 1.16%
743,649
+97,417
+15% +$4.89M
AIMC
27
DELISTED
Altra Industrial Motion Corp
AIMC
$39.6M 1.16%
1,431,470
+389,595
+37% +$11.1M
PBH icon
28
Prestige Consumer Healthcare
PBH
$2.47B
$39.1M 1.15%
1,128,429
+146,699
+15% +$4.83M
DY icon
29
Dycom Industries
DY
$11.2B
$39M 1.14%
763,059
+113,258
+17% +$5.72M
SLRC icon
30
SLR Investment Corp
SLRC
$704M
$38.6M 1.13%
1,868,739
+228,027
+14% +$4.69M
MRCY icon
31
Mercury Systems
MRCY
$5.41B
$36.2M 1.06%
445,670
+3,710
+0.8% +$293K
WWE
32
DELISTED
World Wrestling Entertainment
WWE
$36M 1.05%
505,700
+65,537
+15% +$4.7M
SP
33
DELISTED
SP Plus Corporation
SP
$35.3M 1.04%
954,534
+119,682
+14% +$4.17M
HLF icon
34
Herbalife
HLF
$1.3B
$35.2M 1.03%
929,695
+131,666
+16% +$5.14M
NVRI icon
35
Enviri
NVRI
$624M
$35M 1.03%
1,847,505
+997,811
+117% +$21.2M
FLWS icon
36
1-800-Flowers.com
FLWS
$252M
$34.7M 1.02%
2,343,444
-60,920
-3% -$1.05M
PACW
37
DELISTED
PacWest Bancorp
PACW
$33.2M 0.97%
914,289
+119,207
+15% +$4.31M
NDAQ icon
38
Nasdaq
NDAQ
$53.4B
$33.2M 0.97%
1,003,080
+49,323
+5% +$1.64M
MATW icon
39
Matthews International
MATW
$887M
$33M 0.97%
933,261
+121,833
+15% +$4M
SLGN icon
40
Silgan Holdings
SLGN
$4.51B
$33M 0.97%
1,098,455
+142,090
+15% +$4.28M
UTL icon
41
Unitil
UTL
$989M
$32.6M 0.96%
513,751
+60,005
+13% +$3.6M
TCF
42
DELISTED
TCF Financial Corporation Common Stock
TCF
$32.4M 0.95%
850,226
+111,473
+15% +$4.43M
IWM icon
43
iShares Russell 2000 ETF
IWM
$79.1B
$31.9M 0.94%
211,096
+6,523
+3% +$996K
CHCT
44
Community Healthcare Trust
CHCT
$536M
$31.3M 0.92%
702,989
+88,811
+14% +$3.74M
FFBC icon
45
First Financial Bancorp
FFBC
$3.55B
$29.7M 0.87%
1,213,591
-44,825
-4% -$1.08M
UMPQ
46
DELISTED
Umpqua Holdings Corp
UMPQ
$29.6M 0.87%
1,797,918
+234,539
+15% +$3.85M
NOVT icon
47
Novanta
NOVT
$4.91B
$29.6M 0.87%
361,735
+11,200
+3% +$910K
B
48
DELISTED
Barnes Group Inc.
B
$28.1M 0.82%
545,386
-60,107
-10% -$3.01M
DBI icon
49
Designer Brands
DBI
$315M
$28M 0.82%
1,635,788
+256,759
+19% +$4.35M
BBT
50
Beacon Financial Corp
BBT
$2.5B
$27.7M 0.81%
945,518
+124,113
+15% +$3.78M

Similar funds

Aristotle Capital Boston's Q3 2019 Portfolio in Review

As of Q3 2019, Aristotle Capital Boston held 129 positions worth $3.41B, up 6.5% from $3.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Aristotle Capital Boston deployed $293M of net new capital in Q3 2019, opening 4 new positions and adding to 103 existing holdings. Its largest new stake was Treehouse Foods: 358,099 shares worth $19.9M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was HEICO Corp Class A, an estimated $16.5M trimmed.

  • Aristotle Capital Boston's largest Q3 2019 buy was Treehouse Foods: 358,099 shares worth $19.9M.
  • Aristotle Capital Boston added most to Enviri in Q3 2019, an estimated $21.2M increase.
  • Aristotle Capital Boston's biggest Q3 2019 reduction was HEICO Corp Class A, cutting an estimated $16.5M.
  • Aristotle Capital Boston fully exited Electronics for Imaging in Q3 2019, selling an estimated $57.1M.
  • Aristotle Capital Boston's ten largest holdings make up 19% of its $3.41B portfolio in Q3 2019.
  • Aristotle Capital Boston opened 4 new positions and closed 1 in Q3 2019.
  • Aristotle Capital Boston's portfolio value rose 6.5% quarter-over-quarter to $3.41B.

Based on Aristotle Capital Boston's 13F filing for Q3 2019, filed 14 Nov 2019.